178 filings
Page 7 of 9
8-K
f3pzlhgl
31 May 16
FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBC
12:00am
8-K
0s3dgoyi430v8e6 1n
25 May 16
Other Events
12:00am
8-K
7vofqtioxz8g
5 May 16
Intercept Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
prrx5q 0qh9ejws3
3 May 16
Other Events
12:00am
8-K
70u5jywkqap3jezix37
8 Apr 16
FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva™ (obeticholic acid) for the Treatment of PBC
12:00am
8-K
utd2iei
23 Feb 16
Intercept Pharmaceuticals Reports 2015 Financial Results and Provides Business Update
12:00am
8-K
69utwp p6ry1dgax1
17 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
jjilbbo i9botksz4
29 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
k87pc9 5ejnnt9m3ysc
27 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K/A
kypnxw o572shac5
11 Dec 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
y3qtc68
1 Dec 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
o64bs9 m6nuwx9796a
1 Dec 15
Regulation FD Disclosure
12:00am
8-K
q7cvqr l9i
9 Nov 15
Intercept Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Business Update
12:00am
8-K
7j1r8ty9jqzxdwwo
7 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
qewz6d4spj
8 Sep 15
Other Events
12:00am
8-K
odr9 5abay4z
5 Aug 15
Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update
12:00am
8-K
ovl5z
30 Jun 15
Other Events
12:00am
8-K
mz2gr6npar73jncgbr1
11 May 15
Intercept Pharmaceuticals Announces First Quarter 2015 Financial Results
12:00am
8-K
cgfzov
2 Apr 15
Intercept Pharmaceuticals Announces Proposed Offering of Common Stock
12:00am
8-K
u4vs609dep9sbgi17 37
2 Mar 15
Intercept Pharmaceuticals Announces 2014 Financial Results
12:00am